Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents

1. Iborra, M.
2. Beltrán, B.
3. Maroto, N.
4. Navarro-Cortés, P.
5. Boscá-Watts, M.
6. Ferrer-Bradley, I.
7. García-Morales, N.
8. Sáez-González, E.
9. Hinojosa, J.
10. Mínguez, M.
11. Nos, P.